Summer Symposium 2013

Cancer Immunology and Immunotherapy

The 12th Annual Koch Institute Summer Symposium was held on Friday, June 14, 2013 at Kresge Auditorium on the MIT campus. This year’s symposium was focused on Cancer Immunology and Immunotherapy. During the one-day program, cancer researchers, tumor immunologists and clinical oncologists helped to unravel the complexities of the immune system's interactions with developing tumors, as well as provide updates on the latest breakthroughs and challenges in the immunotherapeutic treatment of cancer.

Speakers and Presentations

Tyler Jacks

Opening Remarks

Tyler Jacks, Ph.D
Director, Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology 

View Video

Introduction and Overview

Darrell Irvine
Professor, Departments of Biological Engineering and Materials Science & Engineering
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

View Video

Engineering CARs and TCRs for Cancer

Carl June
Richard W. Vague Professor in Immunotherapy
Department: Pathology and Laboratory Medicine
University of Pennsylvania

The PD-1/B7-H1 Pathway in Cancer Immunotherapy

Lieping Chen
Professor of Immunobiology, Dermatology and Medicine (Medical Oncology)
Director, Cancer Immunology Program at Yale Cancer Center
Yale University

View Video

Modeling Cancer and Treatment in Humanized Mice

Jianzhu Chen
Cottrell Professor of Immunology
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

View Video

Engineering Single-Cell Bioanalytical Technologies To Evaluate Immune Responses

J. Christopher Love
Latham Family Career Development Associate Professor of Chemical Engineering
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

View Video

Targeting Adjuvant Drugs to Anti-Tumor T-Cells

Darrell Irvine
Professor, Departments of Biological Engineering and Materials Science & Engineering
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

View Video

Tissue T Cells in HPV Disease

Cornelia L. Trimble
Associate Professor
Departments of Gynecology/Obstetrics, Oncology, and Pathology
Johns Hopkins University, School of Medicine

View Video

Infection Mimicking Polymers as Therapeutic Cancer Vaccines

David Mooney
Robert P. Pinkas Family Professor of Bioengineering
Harvard School of Engineering and Applied Sciences

View Video 

Checkpoint Blockade for the Treatment of Cancer

F. Stephen Hodi, M.D.
Associate Professor of Medicine at Harvard Medical School
Dana-Farber Cancer Institute

Synergism Between Antibody and T Cell-Mediated Cancer Immunotherapy

K. Dane Wittrup
Associate Director, Koch Institute for Integrative Cancer Research
Carbon P. Dubbs Professor of Chemical Engineering and Bioengineering
Massachusetts Institute of Technology

View Video

Using Genomics to Elucidate Cancer Immunoediting Mechanisms and Inform Cancer Immunotherapy

Robert Schreiber
Alumni Professor, Pathology and Immunology
Professor, Molecular Microbiology
Washington University School of Medicine

View Video

Tyler Jacks

Closing Remarks

Tyler Jacks, Ph.D
Director, Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology 

View Video

We gratefully acknowledge our sponsors and vendors:

 

Sponsors

Agilent Technologies
Amgen
Aveo Oncology Inc.
Boehringer Ingelheim RCV GmbH & Co KG
Bristol-Myers Squibb
Cell Signaling Technology Inc.
Genentech
Janssen R&D LLC.
MedImmune
Merrimack Pharmaceuticals
Novartis
Regeneron Pharmaceuticals, Inc.
Thermo Fisher Scientific
Transgene

Vendors

Beckman Coulter
Cell Signaling Technology Inc.
EDP Millipore
Integrated DNA Technologies
LABPREPCO
Qiagen
Taconic
Teledyne Isco